MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Salivary and Plasma Heme Oxygenase-1 Concentration as a New Potential Biomarker in Parkinson Disease

    R. Yadav (Kathmandu, Nepal)

    Objective: The objective was to assess the utility of plasma and salivary heme oxygenase-1 (HO-1) concentration as a new potential biomarker for the diagnosis of…
  • 2024 International Congress

    Validation of Inertial Monitoring Units for Gait Assessment in Progressive Supranuclear Palsy

    A. Blazek, C. Hogen, J. Whitwell, K. Josephs, K. Kaufman, F. Ali (Rochester, USA)

    Objective: To evaluate the validity and precision of using inertial measurement units (IMU) for measurement of kinematics and spatial-temporal features of gait in progressive supranuclear…
  • 2024 International Congress

    Cardiovascular Associations of Cortical Lewy Bodies in the Oldest Old: The 90+ study

    R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

    Objective: To identify potential risk factors for cortical Lewy Bodies (CLB) in the oldest-old (> 90 years old), we investigated if cardiovascular medical histories, medication…
  • 2024 International Congress

    Association Between DPP-4 Inhibitors Use and Risk of Dementia: A Meta-analysis Using Real-world Data

    S. Hussain (New Delhi, India)

    Objective: To investigate the potential association between the use of DPP-4 inhibitors and the risk of dementia, utilizing real-world data from diverse sources. Background: Evidence…
  • 2024 International Congress

    A case of progressive supranuclear palsy followed by dementia with Lewy bodies

    S. Fujita, H. Kawasaki, R. Yokoyama, Y. Ito, T. Yamamoto (Muroyama-cho, Japan)

    Objective: We report a case of dementia with Lewy bodies (DLB) that was diagnosed one year after the diagnosis of PSP. Background: Progressive supranuclear palsy…
  • 2024 International Congress

    Age-associated presbyvestibulopathy is more severely abnormal in PD compared to the older controls

    N. Bohnen, G. Carli, T. Brown, S. David, J. Barr, R. Vangel, T. Johnson, K. Kerber, D. Mccaslin (Ann Arbor, USA)

    Objective: We aim to investigate differences in specific vestibular tests between individuals diagnosed with Parkinson’s Disease (PD) and elderly healthy controls. With consideration for potential…
  • 2024 International Congress

    String Vessel Formation Regionally Increases in Long Duration Parkinson’s Disease

    D. Dik, GM. Halliday, V. Sytnyk, C. Shepherd (Randwick, Australia)

    Objective: Parkinson's disease is a movement disorder characterised by α-synuclein deposition in the form of Lewy bodies and Lewy neurites. Vascular changes have been thought to contribute…
  • 2024 International Congress

    The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia

    L. Ortega-Bolaños, G. Pinilla-Monsalve, V. Martinez-Villota (Cali, Colombia)

    Objective: To elucidate the clinical presentation of Progressive Supranuclear Palsy (PSP) in a cohort residing in underserved communities in Buenaventura, Colombia—the country's primary maritime port…
  • 2024 International Congress

    Pisa Syndrome as an early presenting feature of Corticobasal Ganglionic degeneration [CBGD]

    M. Matta, N. Sawal, A. Prasad (Chandigarh, India)

    Objective: To describe Pisa syndrome as an early presenting feature of CBGD and add to literature on CBGD so that neurologists can suspect CBGD when…
  • 2024 International Congress

    Parkinson’s disease in a Special Population -Diagnosis and treatment of Parkinson’s disease in cases of psychiatric disorders treated with dopamine receptors antagonists-

    M. Nomoto, S. Oda, H. Doi (Imabari, Japan)

    Objective: We studied diagnosis and treatment of Parkinson’s disease in cases of psychiatric disorders treated with dopamine receptors antagonists for a long time. Background: Schizophrenia…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley